The DOI matches its Crossref record.
WHO Handbook for Reporting Results of Cancer Treatment
Open accessAbstract
pages on lung carcinoma, and Taxy & Battifora's 70 pages on soft-tissue tumours (each with an impressive reference list of almost 200 citations) will be welcomed by workers in these fields as major reviews. The tumour theme is further explored in a shorter but none the less pertinent and valuable account of prostatic carcinoma by Tannen-baum & Tannenbaum, a chapter interesting for its inclusion of scanning EM as a diagnostically useful technique in an area where the transmission mode predominates. Churg, Spargo, Sakaguchi & Jones' detailed appraisal of one of the earliest and most important areas of application ("Diagnostic Electron Microscopy of Renal Disease") is a substantial account of over 100 pages and is lavishly illustrated (most illustrations being of full-page size). It will be essential reading for any histopathologist encountering renal material, though, despite its title, the chapter omits neoplastic conditions of the kidney. Wood & Hu's "Diagnostic Electron Microscopy of the Skin", covers neoplastic and non-neoplastic conditions. This is an excellent treatment of the subject, with some exceptionally fine illustrations. The volume culminates in a comprehensive treatment by Bloodworth, Horvath & Kovacs on the "Fine Structural Pathology of the Endocrine Sys-tem". This chapter, in keeping intellectually and presentationally with the rest of the volume, must be considered a significant contribution to this field. "Diagnostic Electron Microscopy volume 3", in summary, will provide histopatholo-gists with access to or an interest in electron microscopy with authoritative treatments of several major areas of tumour and non-tumour application: it will be particularly welcomed by those specializing in neoplasia. The price of over £50 cannot be considered high for such a quality volume of over 500 pages. B. EDEN New Frontiers in Mammary Pathology. It is the proceedings of a symposium held in Paris in December, 1979 and had reached the bookshops in 1981 at the exhorbitant price of £39.50. The papers were all by invited speakers (9 from France; 2 from Belgium; 2 from U.S.A.; one each from U.K. and Switzerland) and, whilst some of the work described was recent or in progress, many of the "frontiers" being reviewed were passed well before the conference took place. Indeed in some sections, e.g. those on "The Natural History of Benign Breast Tumours" and on "Cystosarcoma phyllodes", there are no new ideas or observations at all, merely pedestrian accounts which would scarcely be adequate in a standard text book. There is little in this …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Bartelink, H., Roelofsen, F., Eschwege, F., Rougier, P., Bosset, J. F., Gonzalez, D. G., Peiffert, D., van Glabbeke, M., & Pierart, M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2040 · Cited by 1,319
Malmström, A., Grønberg, B. H., Marosi, C., Stupp, R., Frappaz, D., Schultz, H., Abacioglu, U., Tavelin, B., Lhermitte, B., Hegi, M. E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70265-6 · Cited by 1,286
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
Schaake-Koning, C., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260805 · Cited by 1,277
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Van Cutsem, E., Twelves, C., Cassidy, J., Allman, D., Bajetta, E., Boyer, M., Bugat, R., Findlay, M., Frings, S., Jahn, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4097 · Cited by 1,032
Marty, M., Sersa, G., Garbay, J. R., Gehl, J., Collins, C. G., Snoj, M., Billard, V., Geertsen, P. F., Larkin, J. O., Miklavcic, D., et al. (2006) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2006.08.002 · Cited by 908
Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90535-5 · Cited by 885
Kaufman, B., Mackey, J. R., Clemens, M. R., Bapsy, P. P., Vaid, A., Wardley, A., Tjulandin, S., Jahn, M., Lehle, M., Feyereislova, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6847 · Cited by 843
Zaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
Lawitz, E., Sulkowski, M. S., Ghalib, R., Rodriguez-Torres, M., Younossi, Z. M., Corregidor, A., DeJesus, E., Pearlman, B., Rabinovitz, M., Gitlin, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61036-9 · Cited by 818
Smith, I. E., Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Blohmer, J.-U., Ashley, S. E., Francis, S., Boeddinghaus, I., & Walsh, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.005 · Cited by 774
INTERNATIONALCOLLABORATIVEHYPERT, VERNON, C., HAND, J., FIELD, S., MACHIN, D., WHALEY, J., ZEE, J., VANPUTTEN, W., VANRHOON, G., & VANDIJK, J. (1996) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/0360-3016(96)00154-x · Cited by 725
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review
Aerts, H. J. W. L. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2631 · Cited by 669
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
ten Bokkel Huinink, W., Gore, M., Carmichael, J., Gordon, A., Malfetano, J., Hudson, I., Broom, C., Scarabelli, C., Davidson, N., Spanczynski, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2183 · Cited by 663
New guidelines to evaluate the response to treatment in solid tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2005) · Breast Cancer · doi:10.1007/bf02967383 · Cited by 663
Bone Imaging in Metastatic Breast Cancer
Hamaoka, T., Madewell, J. E., Podoloff, D. A., Hortobagyi, G. N., & Ueno, N. T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.181 · Cited by 656
Flinn, I. W., van der Jagt, R., Kahl, B. S., Wood, P., Hawkins, T. E., MacDonald, D., Hertzberg, M., Kwan, Y.-L., Simpson, D., Craig, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-531327 · Cited by 643
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Isayama, H., Komatsu, Y., Tsujino, T., Sasahira, N., Hirano, K., Toda, N., Nakai, Y., Yamamoto, N., Tada, M., Yoshida, H., et al. (2004) · Gut · doi:10.1136/gut.2003.018945 · Cited by 636
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Giacchetti, S., Itzhaki, M., Gruia, G., Adam, R., Zidani, R., Kunstlinger, F., Brienza, S., Alafaci, E., Bertheault-Cvitkovic, F., Jasmin, C., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008347829017 · Cited by 606
Scagliotti, G. V. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg059 · Cited by 593
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Adam, R., Wicherts, D. A., de Haas, R. J., Ciacio, O., Lévi, F., Paule, B., Ducreux, M., Azoulay, D., Bismuth, H., & Castaing, D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9273 · Cited by 590
Claudon, M., Dietrich, C., Choi, B., Cosgrove, D., Kudo, M., Nolsøe, C., Piscaglia, F., Wilson, S., Barr, R., Chammas, M., et al. (2012) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0032-1325499 · Cited by 550
Improved Endpoints for Cancer Immunotherapy Trials
Hoos, A., Eggermont, A. M. M., Janetzki, S., Hodi, F. S., Ibrahim, R., Anderson, A., Humphrey, R., Blumenstein, B., Old, L., & Wolchok, J. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq310 · Cited by 518
Dietrich, C. F., Nolsøe, C. P., Barr, R. G., Berzigotti, A., Burns, P. N., Cantisani, V., Chammas, M. C., Chaubal, N., Choi, B. I., Clevert, D.-A., et al. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.04.030 · Cited by 498
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3537 · Cited by 495
Standardising outcomes for clinical trials and systematic reviews
Clarke, M. (2007) · Trials · doi:10.1186/1745-6215-8-39 · Cited by 483
Xiong, H. Q., Rosenberg, A., LoBuglio, A., Schmidt, W., Wolff, R. A., Deutsch, J., Needle, M., & Abbruzzese, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.040 · Cited by 479
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
Ross, P. J., Ashley, S., Norton, A., Priest, K., Waters, J. S., Eisen, T., Smith, I. E., & O'Brien, M. E. R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601781 · Cited by 476
Electrochemotherapy in treatment of tumours
Sersa, G., Miklavcic, D., Cemazar, M., Rudolf, Z., Pucihar, G., & Snoj, M. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.05.016 · Cited by 459
Andtbacka, R. H. I., Collichio, F., Harrington, K. J., Middleton, M. R., Downey, G., Ӧhrling, K., & Kaufman, H. L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0623-z · Cited by 455
Late effects of radiation therapy in the head and neck region
Cooper, J. S., Fu, K., Marks, J., & Silverman, S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00421-g · Cited by 453
Wiegel, T., Bartkowiak, D., Bottke, D., Bronner, C., Steiner, U., Siegmann, A., Golz, R., Störkel, S., Willich, N., Semjonow, A., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.03.011 · Cited by 440
Cancer immunotherapy – revisited
Lesterhuis, W. J., Haanen, J. B. A. G., & Punt, C. J. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3500 · Cited by 427
Baselga, J., Carbonell, X., Castañeda-Soto, N.-J., Clemens, M., Green, M., Harvey, V., Morales, S., Barton, C., & Ghahramani, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.014 · Cited by 425
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Herbert, R. D., & Gabriel, M. (2002) · BMJ · doi:10.1136/bmj.325.7362.468 · Cited by 404
Yeh, E., Slanetz, P., Kopans, D. B., Rafferty, E., Georgian-Smith, D., Moy, L., Halpern, E., Moore, R., Kuter, I., & Taghian, A. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 403
Leffers, N., Gooden, M. J. M., de Jong, R. A., Hoogeboom, B.-N., ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G. J., Daemen, T., & Nijman, H. W. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0583-5 · Cited by 402
de Gramont, A., Vignoud, J., Tournigand, C., Louvet, C., André, T., Varette, C., Raymond, E., Moreau, S., Le Bail, N., & Krulik, M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00370-x · Cited by 386
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
Gortzak, E., Azzarelli, A., Buesa, J., Bramwell, V. H. C., van Coevorden, F., van Geel, A. N., Ezzat, A., Santoro, A., Oosterhuis, J. W., van Glabbeke, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00083-1 · Cited by 379
Bjordal, K., & Kaasa, S. (1992) · Acta Oncologica · doi:10.3109/02841869209108178 · Cited by 378
Güngör, T., Teira, P., Slatter, M., Stussi, G., Stepensky, P., Moshous, D., Vermont, C., Ahmad, I., Shaw, P. J., da Cunha, J. M. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62069-3 · Cited by 377
Gregor, A., Cull, A., Stephens, R. J., Kirkpatrick, J. A., Yarnold, J. R., Girling, D. J., Macbeth, F. R., Stout, R., & Machin, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00135-4 · Cited by 371
Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis
Mali, B., Jarm, T., Snoj, M., Sersa, G., & Miklavcic, D. (2013) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2012.08.016 · Cited by 353
Meaning in life and physical health: systematic review and meta-analysis
Czekierda, K., Banik, A., Park, C. L., & Luszczynska, A. (2017) · Health Psychology Review · doi:10.1080/17437199.2017.1327325 · Cited by 348
Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.
Sørensen, J. B., Hansen, H. H., Hansen, M., & Dombernowsky, P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1474 · Cited by 339
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
Sutphen, R., Xu, Y., Wilbanks, G. D., Fiorica, J., Grendys, E. C., LaPolla, J. P., Arango, H., Hoffman, M. S., Martino, M., Wakeley, K., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1185.13.7 · Cited by 338
Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment
Hess, V., A'Hern, R., Nasiri, N., King, D. M., Blake, P. R., Barton, D. P. J., Shepherd, J. H., Ind, T., Bridges, J., Harrington, K., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.078 · Cited by 333
Gilligan, D., Nicolson, M., Smith, I., Groen, H., Dalesio, O., Goldstraw, P., Hatton, M., Hopwood, P., Manegold, C., Schramel, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60714-4 · Cited by 323
Bredin, M., Corner, J., Krishnasamy, M., Plant, H., Bailey, C., & A'Hern, R. (1999) · BMJ · doi:10.1136/bmj.318.7188.901 · Cited by 322
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Roberts, T. G. (2004) · JAMA · doi:10.1001/jama.292.17.2130 · Cited by 319
Van Cutsem, E., Findlay, M., Osterwalder, B., Kocha, W., Dalley, D., Pazdur, R., Cassidy, J., Dirix, L., Twelves, C., Allman, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1337 · Cited by 318
Roszkowski, K., Pluzanska, A., Krzakowski, M., Smith, A. P., Saigi, E., Aasebo, U., Parisi, A., Pham Tran, N., Olivares, R., & Berille, J. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00094-5 · Cited by 308
Fumoleau, P., Largillier, R., Clippe, C., Dièras, V., Orfeuvre, H., Lesimple, T., Culine, S., Audhuy, B., Serin, D., Curé, H., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.007 · Cited by 305
O’Shaughnessy, J. A., Blum, J., Moiseyenko, V., Jones, S. E., Miles, D., Bell, D., Rosso, R., Mauriac, L., Osterwalder, B., Burger, H.-U., et al. (2001) · Annals of Oncology · doi:10.1023/a:1012281104865 · Cited by 304
Measures of Response: RECIST, WHO, and New Alternatives
Jaffe, C. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5599 · Cited by 302
Garcia-Carbonero, R., Supko, J. G., Manola, J., Seiden, M. V., Harmon, D., Ryan, D. P., Quigley, M. T., Merriam, P., Canniff, J., Goss, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.098 · Cited by 294
Bisphosphonates for the relief of pain secondary to bone metastases
Wong, R. K., & Wiffen, P. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002068 · Cited by 285
Ives, N. J., Stowe, R. L., Lorigan, P., & Wheatley, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0253 · Cited by 284
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
Bleehen, N. M., Newlands, E. S., Lee, S. M., Thatcher, N., Selby, P., Calvert, A. H., Rustin, G. J., Brampton, M., & Stevens, M. F. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.910 · Cited by 282
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
Tirkes, T., Hollar, M. A., Tann, M., Kohli, M. D., Akisik, F., & Sandrasegaran, K. (2013) · RadioGraphics · doi:10.1148/rg.335125214 · Cited by 279
Giaccone, G., Splinter, T. A., Debruyne, C., Kho, G. S., Lianes, P., van Zandwijk, N., Pennucci, M. C., Scagliotti, G., van Meerbeeck, J., van Hoesel, Q., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2133 · Cited by 275
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Costelloe, C. M., Chuang, H. H., Madewell, J. E., & Ueno, N. T. (2010) · Journal of Cancer · doi:10.7150/jca.1.80 · Cited by 270
Beelen, D. W., Elmaagacli, A., Müller, K.-D., Hirche, H., & Schaefer, U. W. (1999) · Blood · doi:10.1182/blood.v93.10.3267.410k22_3267_3275 · Cited by 270
André, T., Louvet, C., Maindrault-Goebel, F., Couteau, C., Mabro, M., Lotz, J. P., Gilles-Amar, V, Krulik, M., Carola, E., Izrael, V, et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00150-1 · Cited by 267
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
van Dalen, E. C., Michiels, E. M. C., Caron, H. N., & Kremer, L. C. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005006.pub4 · Cited by 265
The RECIST criteria: implications for diagnostic radiologists
Padhani, A. R., & Ollivier, L. (2001) · The British Journal of Radiology · doi:10.1259/bjr.74.887.740983 · Cited by 263
Huguenin, P., Beer, K. T., Allal, A., Rufibach, K., Friedli, C., Davis, J. B., Pestalozzi, B., Schmid, S., Thöni, A., Ozsahin, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.193 · Cited by 262
McCulloch, M., See, C., Shu, X.-J., Broffman, M., Kramer, A., Fan, W.-Y., Gao, J., Lieb, W., Shieh, K., & Colford, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6392 · Cited by 257
Gentet, J.-C., Brunat-Mentigny, M., Demaille, M. C., Pein, F., Avet-Loiseau, H., Berger, C., De Lumley, L., Pacquement, H., Schmitt, C., Sariban, E., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00439-x · Cited by 86
Efficacy of Melatonin in prevention of radiation-induced oral mucositis: A randomized clinical trial
Elsabagh, H. H., Moussa, E., Mahmoud, S. A., Elsaka, R. O., & Abdelrahman, H. (2020) · Oral Diseases · doi:10.1111/odi.13265 · Cited by 65
Velasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59
Topuz, E., Derin, D., Can, G., Kürklü, E., Çınar, S., Aykan, F., Çevikbaş, A., Dişçi, R., Durna, Z., Şakar, B., et al. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9171-y · Cited by 49
Metadata
- Authors
- Palmer, M. K.
- Venue
- British Journal of Cancer
- Published
- 1982-03
- Volume
- 45
- Issue
- 3
- Pages
- 484-485
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2028269517
- Cited by
- 2,198
- References
- 0
- Type
- book review
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.